Patient Outcomes

Likelihood not to return to work after head and neck cancer treatment is high

Likelihood not to return to work after head and neck cancer treatment is high

Current unemployment for head and neck cancer survivors linked to harder physical work, surgical treatment, and risky alcohol consumption.

Pulmonologist management helpful for NSCLC

Pulmonologist management helpful for NSCLC

Improved rates of stage-specific treatment for early- and advanced-stage non-small-cell lung cancer (NSCLC) with comorbid COPD were linked to a pulmonologist's management.

ASCO: Active surveillance for prostate cancer may decrease survival odds for some

ASCO: Active surveillance for prostate cancer may decrease survival odds for some

When active surveillance is chosen, survival for intermediate-risk disease may be decreased.

Considerable practice variation among surgeons in selecting patients for radical prostatectomy

Considerable practice variation among surgeons in selecting patients for radical prostatectomy

Variation was observed at a high-volume center when surgeons selected patients with low-risk prostate cancer to undergo radical prostatectomy, according to a study.

Women with atypical hyperplasia are at higher risk of breast cancer

By

A new study has better established the future risk of developing breast cancer for those with atypical hyperplasia of the breast.

Test predicts response to treatment for graft-versus-host disease (GVHD)

By

A new test may reveal which patients will respond to treatment for graft-versus-host disease (GVHD), a serious complication that can arise from stem cell SCT.

Risk for leukemia after treatment for early stage breast cancer higher than reported

By

According to results of a new, retrospective study, the risk of developing leukemia after radiation therapy or chemotherapy for early stage breast cancer is double that previously reported.

International collaboration sets stage for better lung cancer surgery outcomes

By

The Society of Thoracic Surgeons (STS) and the European Society of Thoracic Surgery (ESTS) plan to link their outcomes data on chest procedures, in an effort to improve patient care.

Laparoscopic surgery for bladder cancer leads to good long-term cancer control

By

The long-term survival rates following laparoscopic surgery for bladder cancer are not unlike survival rates for open surgery, according to research.

Trastuzumab improves long-term survival of HER2-positive breast cancer patients

By

Trastuzumab significantly improves the long-term survival of HER-2 positive breast cancer patients, according to a large national study.

Effectiveness of drugs to prevent hepatitis among patients receiving chemotherapy

Use of the antiviral drug entecavir resulted in a lower incidence of hepatitis B virus (HBV)-related hepatitis and HBV reactivation among patients with lymphoma undergoing a certain type of chemotherapy.

Using genomic correlates of radiotoxicity to predict patient outcomes

Using genomic correlates of radiotoxicity to predict patient outcomes

By

Radiogenomics is maturing into a predictor of patients' likelihood of experiencing radiotoxicities and late radiation effects.

Time to treatment initiation increasing for patients with head and neck cancer

Time to treatment initiation increasing for patients with head and neck cancer

Biggest increase for time to treatment initiation seen for head and neck cancer patients with advanced disease, chemoradiation, or undergoing treatment at academic center.

Hispanic women less likely to survive endometrial uterine cancer

By

Hispanic women in the United States were significantly less likely to survive endometrial uterine cancer than non-Hispanic white women.

Young adults with acute lymphoblastic leukemia (ALL) benefit from therapies developed for children

By

There is increasing evidence that adolescent and young adult patients with acute lymphoblastic leukemia (ALL) tend to fare better when treated with high-intensity pediatric protocols than standard adult regimens.

Older patients with breast cancer still undergo radiation despite its limited benefit

By

Women over 70 years with early stage breast cancer are very likely to receive radiation therapy, despite evidence of that it might not be the best form of treatment.

Mistletoe: The holiday plant is making headlines as an alternative cancer treatment

Mistletoe: The holiday plant is making headlines as an alternative cancer treatment

By

Most people know of the traditional use of mistletoe to get a kiss from a loved one during the Christmas holiday. However, US oncologists are discovering a new use for the plant as a CAM treatment for cancer.

New kind of targeted drug is promising for patients with leukemia

New kind of targeted drug is promising for patients with leukemia

By

Patients with advanced leukemia, when treated with a new type of cancer therapy that blocks mutated IDH2 protein, showed dramatic results in a clinical trial.

Investigational cellular therapy promising for pediatric ALL and for lymphoma

By

Pediatric patients with acute lymphoblastic leukemia (ALL) showed a 90% response rate from the first trials testing an investigational personalized cellular therapy known as CTL019.

Immunotherapy shows clinical benefit in relapsed transplant recipients

Immunotherapy shows clinical benefit in relapsed transplant recipients

By

Almost half of patients with blood cancer who had relapsed following allogeneic stem cell transplantation benefitted from treatment with the immune checkpoint blocker ipilimumab.

Experience counts with radiation for head and neck cancer

By

The effectiveness of radiation therapy used to treat head and neck cancer could depend in part on clinician experience, according to a new study.

Managing oral side effects of irinotecan therapy

Managing oral side effects of irinotecan therapy

By

Is there an effective way to manage the oral side effects of irinotecan therapy?

Results confirm long-term success of laser treatment for vocal cord cancer

By

The first long-term study of a pioneering endoscopic laser treatment for early vocal cord cancer, previously shown to provide optimal voice outcomes, finds that it is as successful as traditional approaches in curing patients' tumors.

Clear excision margins vital for stage Ia1 squamous cervical cancer management

Clear excision margins vital for stage Ia1 squamous cervical cancer management

Women with clear surgical margins after the initial excision are more likely to remain disease-free.

Life expectancy still not used to determine aggressiveness of prostate cancer treatment

By

More than half of prostate cancer patients age 66 years and older have life expectancies of less than 10 years, yet half of them were over-treated for their prostate cancer with surgery, radiation, or brachytherapy.

Many breast cancer patients do not receive shorter radiation treatment

By

Although the use of a radiation treatment that is shorter in duration and less costly has increased among women with early stage breast cancer who underwent breast conserving surgery, most patients who meet guidelines to receive this treatment do not.

Quantifying mental disorders in patients with cancer

Quantifying mental disorders in patients with cancer

By

Researchers in Germany interviewed more than 2,000 patients with cancer to gather epidemiologic data on mental health of patients with cancer.

Gefitinib effective in older, African American patients with non-small cell lung cancer (NSCLC)

By

Researchers have found that an FDA-approved therapy could be effective in treating both older and African American patients with advanced lung cancer who may not be candidates for chemotherapy.

Organ preservation in kidney cancer more likely at facilities that are early adopters of robotic surgery

By

Patients with operable kidney cancers were more likely to have a partial nephrectomy, which is the recommended treatment for localized tumors, when treated in hospitals that were early adopters of robotic surgery, according to a new study.

Antacids linked to better survival in patients with head and neck cancer

By

Patients with head and neck cancer who used antacid medicines to control acid reflux had better overall survival, according to a new study.

April Contest

Click here to get started

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs